Cradle's software platform empowers biology R&D teams with generative Machine Learning models to design better proteins in less time. On the platform your team can easily generate new protein designs from state-of-the art models. Data from your wet lab improves the model after every iteration. Cradle, founded Oct 2021 in the Netherlands and Switzerland, is trusted by industry leaders including Johnsson & Johnsson Innovation, Grifols, Twist Bioscience and Novozymes. Teams working on enzymes, vaccines, peptides or other protein therapeutics use Cradle to optimize properties such as stability, activity, binding, efficacy, and expression.